Sars-cov-2 Pneumonia
📧 Sign up to get email alerts when something new happens for Sars-cov-2 Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Macrophage Regulation of Ozone-Induced Lung Inflammation [Phase 1]
Phase 1 clinical trial update investigating how macrophages regulate ozone-induced lung inflammation in patients with SARS-CoV-2 pneumonia; …
-
CLINICAL_TRIALS withdrawal · 2021-02-05Clinical Trial Update: Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial [Phase 4]
A Phase 4 trial evaluating hydroxychloroquine for SARS-CoV-2 pneumonia/COVID-19 has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia. [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating inhaled exosome therapy for safety and efficacy in COVID-19–associated pneumonia has completed with resu…
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: Hydroxychloroquine, Azithromycin in the Treatment of Covid-19 [Phase 3]
Phase 3 clinical trial update involving hydroxychloroquine and azithromycin for SARS-CoV-2 pneumonia and COVID-19; status is unknown.